Developing a Fall-Risk Test for Adults with Neuromuscular Disorders
Tests a fall-risk scoring tool in adults with neuromuscular disorders such as myasthenia gravis.
Plain-language title generated from the registry record
Registry title: Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
Key facts
- Where
- München, GermanySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06605612, who can take part
Where in Germany
- Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, LMU Klinikum, Ludwig-Maximilians-Universität MünchenMünchen, GermanyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- LMU Klinikum
- Trial code
- NCT06605612
- Record updated
- 10 September 2025
- Original description
Currently, there are no standardised fall risk scores or guidelines on when to use appropriate assistive gait devices (AGDs) for people with neuromuscular disorders (NMDs). There is a clear medical unmet need to provide a battery of appropriate locomotor gait assessments to determine the risk of falling for patients with NMDs and give clear guidelines to prescribe an appropriate AGD.Read full original descriptionShow less
Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders
Currently, there are no standardised fall risk scores or guidelines on when to use appropriate assistive gait devices (AGDs) for people with neuromuscular disorders (NMDs). There is a clear medical unmet need to provide a battery of appropriate locomotor gait assessments to determine the risk of falling for patients with NMDs and give clear guidelines to prescribe an appropriate AGD.
The primary goal is to confirm whether the clinical battery assessments (Heel-Rise Test (HRT), Chair-Rise Test (CRT), Semi-tandem Stand (STS), Trunk-Rise Test (TRT), Foot-Tapping Test (FTT), Timed Up and Go (TUG), 10-Meter-Walk Test (10MWT) and 6-Minute-Walk Test (6MWT) can be validated and generalized to other NMD target populations that meet broader eligibility criteria based on used clinical assessments. The second objective of this project is to provide intra- and inter-observer reliability and test-retest reliability of included clinical assessments used to determine the risk of falling for patients with NMDs. Finally, all data will be compared with norm data from the healthy population (n=15) collected retrospectively.
Inclusion: Only patients with adequate cognitive and communicative function to give informed consent and to fill out the scale assessing the risk of falling will be included.
Exclusion: Patients who had knee, hip or back surgery in the last three months; Patients who are unable to walk without AGD for at least 10 meters; Patients who suffer from polyneuropathy or peripheral neuropathy.